Pharmacotherapies for attention-deficit/hyperactivity disorder: expected-cost analysis

Authors: Marchetti A.; Magar R.¹; Lau H.; Murphy E.L.; Jensen P.S.; Conners C.K.; Findling R.; Wineburg E.; Carotenuto I.; Einarson T.R.; Iskedjian M.

Source: Clinical Therapeutics, Volume 23, Number 11, November 2001 , pp. 1904-1921(18)

Publisher: Elsevier

Keywords: attention-deficit/hyperactivity disorder; psychostimulants; economic; methylphenidate; amphetamine

Language: English

Document Type: Research article

DOI: 10.1016/S0149-2918(00)89086-4

Affiliations: 1: Health Economics Research, Secaucus, New Jersey, U.S.A.

Links for this article

http://www.ingentaconnect.com/els/01492918/2001/00000023/00000011/art89086
http://openurl.ingenta.com/content?genre=article&issn=0149-2918&volume=23&issue=11&spage=1904&epage=1921
http://dx.doi.org/10.1016/S0149-2918(00)89086-4